Fundamental and clinical studies on Cefroxadine in the field of oral surgery.
スポンサーリンク
概要
- 論文の詳細を見る
Fundamental and clinical studies in the field of oral surgery were carried out on Cefro-xadine (CXD) . The following results were obtained.<BR>1) Antibacterial activity of CXD was compared with CCL, CEX and AMPC. Results show that it was similar or slightly superior to CEX and was slightly inferior to CCL.<BR>2) The concentrations in serum and the oral tissues 60 minutes after administration of 500mg in fasting objects were 13.2+1.4μg/ml (mean ±S.E.) in serum, 65.1±1.2μg/ml (mean ±S.E.) in gingiva and 0.18μg/g in dental follicle. The mean serum concentration in non fasting objects were 0.25μg/ml at 30 min, 0.75μg/ml at 60 min, 5.3μg/ml at 90 min, 10.5μg/ml at 120 min, 6.34μg/ml at 240 min and 1.1μg/ml at 360 min.<BR>3) Fifteen cases with oral infections were treated with 1, 500 mg Cefroxadine per day. Therapeutic responses were good in 12 cases, fair in 1 case and poor in 2 cases ; the efficacy rate was 80%.<BR>4) Side effects associated with CXD were not noted except for 1 case of exanthema.<BR>5) According to these results, CXD is considered to be a useful antibiotic for mild or moderate oral infections and for prevention of post operative infection.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果